PRPH
ProPhase Labs Inc.
Company Overview
| Mkt Cap | $16.10M | Price | $0.36 |
| Volume | 989.49K | Change | -1.70% |
| P/E Ratio | -0.3 | Open | $0.39 |
| Revenue | $6.8M | Prev Close | $0.37 |
| Net Income | $-53.4M | 52W Range | $0.22 - $2.23 |
| Div Yield | N/A | Target | $11.00 |
| Overall | 39 | Value | 60 |
| Quality | 39 | Technical | 18 |
No chart data available
Stock Overview
Updated DailyProPhase Labs Inc. (PRPH) is a leading Healthcare company in the Drug Manufacturers - Major industry, currently trading at $0.36 with a market capitalization of $16.10 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows PRPH with a volume of 989K shares. The stock opened up 4.68% from yesterday's close of $0.37. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
PRPH demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including MTEX, RELV, USNA, NATR, OGEN.
Key investment considerations for PRPH include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 2924.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 10:48 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRPH | $0.36 | -1.7% | 989.49K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |